Cargando…

Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system

OBJECTIVES: Evidence on the effects of the SARS-CoV-2 Omicron variant on vaccinated and unvaccinated pregnant women is sparse. This study aimed to compare maternal and perinatal outcomes of women infected with SARS-CoV-2 during the Omicron wave in Italy, according to their vaccine protection. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Corsi Decenti, Edoardo, Salvatore, Michele Antonio, Mandolini, Donatella, Donati, Serena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859768/
https://www.ncbi.nlm.nih.gov/pubmed/36693525
http://dx.doi.org/10.1016/j.cmi.2023.01.013
_version_ 1784874434249621504
author Corsi Decenti, Edoardo
Salvatore, Michele Antonio
Mandolini, Donatella
Donati, Serena
author_facet Corsi Decenti, Edoardo
Salvatore, Michele Antonio
Mandolini, Donatella
Donati, Serena
author_sort Corsi Decenti, Edoardo
collection PubMed
description OBJECTIVES: Evidence on the effects of the SARS-CoV-2 Omicron variant on vaccinated and unvaccinated pregnant women is sparse. This study aimed to compare maternal and perinatal outcomes of women infected with SARS-CoV-2 during the Omicron wave in Italy, according to their vaccine protection. METHODS: This national prospective cohort study enrolled pregnant women with a positive SARS-CoV-2 nasopharyngeal swab within 7 days of hospital admission between 1 January and 31 May, 2022. Women who received at least one dose of vaccine during pregnancy and those who completed the vaccine cycle with the first booster were considered protected against moderate or severe COVID-19 (MSCD). A multivariable logistic regression model evaluated the association between vaccine protection and disease severity. Maternal age, educational level, citizenship, area of birth, previous comorbidities, and obesity were analysed as potential risk factors. RESULTS: MSCD was rare (41/2147, 1.9%; 95% CI, 1.4–2.6), and the odds of developing it were significantly higher among unprotected women (OR, 2.78; 95% CI, 1.39–5.57). Compared with protected women (n = 1069), the unprotected (n = 1078) were more often younger, with lower educational degrees, and foreigners. A higher probability of MSCD was found among women with previous comorbidities (OR, 2.86; 95% CI, 1.34–6.12) and those born in Asian countries (OR, 3.05; 95% CI, 1.23–7.56). The percentage of preterm birth was higher among women with MSCD compared with milder cases (32.0% [8/25] versus 8.4% [161/1917], p < 0.001) as well as the percentage of caesarean section (52.0% [13/25] versus 31.6% [606/1919], p 0.029). DISCUSSION: Although severe maternal and perinatal outcomes were rare, their prevalence was significantly higher among women without vaccine protection. Vaccination during pregnancy has the potential to protect both the mother and the baby, and it is therefore strongly recommended.
format Online
Article
Text
id pubmed-9859768
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-98597682023-01-23 Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system Corsi Decenti, Edoardo Salvatore, Michele Antonio Mandolini, Donatella Donati, Serena Clin Microbiol Infect Original Article OBJECTIVES: Evidence on the effects of the SARS-CoV-2 Omicron variant on vaccinated and unvaccinated pregnant women is sparse. This study aimed to compare maternal and perinatal outcomes of women infected with SARS-CoV-2 during the Omicron wave in Italy, according to their vaccine protection. METHODS: This national prospective cohort study enrolled pregnant women with a positive SARS-CoV-2 nasopharyngeal swab within 7 days of hospital admission between 1 January and 31 May, 2022. Women who received at least one dose of vaccine during pregnancy and those who completed the vaccine cycle with the first booster were considered protected against moderate or severe COVID-19 (MSCD). A multivariable logistic regression model evaluated the association between vaccine protection and disease severity. Maternal age, educational level, citizenship, area of birth, previous comorbidities, and obesity were analysed as potential risk factors. RESULTS: MSCD was rare (41/2147, 1.9%; 95% CI, 1.4–2.6), and the odds of developing it were significantly higher among unprotected women (OR, 2.78; 95% CI, 1.39–5.57). Compared with protected women (n = 1069), the unprotected (n = 1078) were more often younger, with lower educational degrees, and foreigners. A higher probability of MSCD was found among women with previous comorbidities (OR, 2.86; 95% CI, 1.34–6.12) and those born in Asian countries (OR, 3.05; 95% CI, 1.23–7.56). The percentage of preterm birth was higher among women with MSCD compared with milder cases (32.0% [8/25] versus 8.4% [161/1917], p < 0.001) as well as the percentage of caesarean section (52.0% [13/25] versus 31.6% [606/1919], p 0.029). DISCUSSION: Although severe maternal and perinatal outcomes were rare, their prevalence was significantly higher among women without vaccine protection. Vaccination during pregnancy has the potential to protect both the mother and the baby, and it is therefore strongly recommended. European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023-06 2023-01-21 /pmc/articles/PMC9859768/ /pubmed/36693525 http://dx.doi.org/10.1016/j.cmi.2023.01.013 Text en © 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Corsi Decenti, Edoardo
Salvatore, Michele Antonio
Mandolini, Donatella
Donati, Serena
Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system
title Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system
title_full Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system
title_fullStr Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system
title_full_unstemmed Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system
title_short Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system
title_sort vaccination against sars-cov-2 in pregnancy during the omicron wave: the prospective cohort study of the italian obstetric surveillance system
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859768/
https://www.ncbi.nlm.nih.gov/pubmed/36693525
http://dx.doi.org/10.1016/j.cmi.2023.01.013
work_keys_str_mv AT corsidecentiedoardo vaccinationagainstsarscov2inpregnancyduringtheomicronwavetheprospectivecohortstudyoftheitalianobstetricsurveillancesystem
AT salvatoremicheleantonio vaccinationagainstsarscov2inpregnancyduringtheomicronwavetheprospectivecohortstudyoftheitalianobstetricsurveillancesystem
AT mandolinidonatella vaccinationagainstsarscov2inpregnancyduringtheomicronwavetheprospectivecohortstudyoftheitalianobstetricsurveillancesystem
AT donatiserena vaccinationagainstsarscov2inpregnancyduringtheomicronwavetheprospectivecohortstudyoftheitalianobstetricsurveillancesystem
AT vaccinationagainstsarscov2inpregnancyduringtheomicronwavetheprospectivecohortstudyoftheitalianobstetricsurveillancesystem